This study additionally focused on the dual role of IL-33 in antitumor activity and identified a critical signaling pathway, p38-GATA3, which promoted the M2 polarization of macrophages and simultaneously fostered tumor progression and resolution of inflammation. The gene discussed is IL33; the disease is neoplasm.